Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis
2021 · Neurotherapeutics · 38 citations
https://doi.org/10.1007/s13311-021-01104-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
151
Citations
5
h-index
5
i10-index
Ilaria Poirè is an academic researcher. The author has contributed to research in topics: Multiple Sclerosis Research Studies & SARS-CoV-2 and COVID-19 Research & Peripheral Neuropathies and Disorders. The author has an h-index of 5, co-authored 10 publications.
Click to start Chat